Hong Kong’s Swire Pacific takes control of Shanghai healthcare provider DeltaHealth
- DeltaHealth operates Shanghai DeltaHealth Hospital, which focuses on cardiovascular diseases, as well as outpatient medical centre DeltaWest Clinic
- The latest investment comes after the Cathay Pacific parent invested in a major Indonesian hospital operator in December
The property to aviation conglomerate, which first invested in the mainland Chinese company in 2021, said it was targeting new growth areas such as healthcare and that this was its first majority stake in a medical services provider. It comes close on the heels of an investment in an Indonesian healthcare group in December.
Swire Pacific did not provide details about its latest investment in DeltaHealth.
“We are very excited to be investing further into DeltaHealth and taking a controlling position,” said Guy Bradley, chairman of Swire Pacific, in a statement on Thursday. “Demand for high-quality healthcare is growing rapidly as income and living standards rise, and we anticipate demand for the treatment of cardiovascular disease to increase in line with these developments.”
DeltaHealth operates Shanghai DeltaHealth Hospital, which focuses on cardiovascular diseases, as well as DeltaWest Clinic, an outpatient clinic in the Gubei area of Changning district, to serve residents in Shanghai and the Yangtze River Delta, according to information on Swire’s website.
“DeltaHealth is one of the leading players in cardiovascular care in Shanghai,” a Swire Pacific spokesman said. “It has recently expanded into thoracic surgery and oncology, adopting a comprehensive multidisciplinary approach towards patient care.”
